Pfizer shareholders elect all 12 director nominees, defeat all four shareholder proposals at 2022 annual meeting

PFIZER INC

All 12 Board nominees elected, including CEO Albert Bourla and independent directors.
Ratification of KPMG as independent auditor for FY2022 approved with 4.44B votes for.
Advisory say-on-pay resolution for named executives approved with 3.51B votes for.
Four shareholder proposals (proxy access, political spending, IP transfer, anticompetitive risks) all defeated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.